Infinium Global Research Transcatheter Mitral Valve Replacement Market | Page 3

Transcatheter Mitral Valve Replacement Market: Trends and Forecast -2023
suffering with mitral regurgitation disease added each year is 250,000. Among
these 4.1 million patients, only about 20% or 1.67 million are eligible for the
treatment. This creates huge opportunity for the global transcatheter mitral valve
replacement market.
In addition, increasing adoption of minimally invasive procedures over traditional
surgical open heart procedures, reduction in hospital stays, low risk of infection,
minimal blood loss are further propelling the market. According to world health
organization (WHO), it has been estimated that the number of people suffering
from cardiovascular diseases will increase to 22.2 million by 2030. The market for
TMVR is expected to reach around USD 3.0 billion by 2022. However, there are
certain restraining factors which could hamper the growth of this market, which
includes, high costs associated with the LMVD implantation compared to other
therapies available for CVD diseases.
Segment Covered
The report on global transcatheter mitral valve replacement market covers product
segment. On the basis of product the global transcatheter mitral valve replacement
market is categorized into transapical implantation and transfemoral implantation.
Geographic Coverage
The report provides regional analysis covering geographies such as Americas,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography is provided over the period of 2015-2023. The
countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives the growth in the North America
region as it is the largest market in the region. The Asia-pacific region offers a
substantial potential for the market growth owing to rapid growth in markets such
as India and China. The APAC region is projected to experience a growth at a CAGR
of x.x% over the period of 2017-2023.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global transcatheter mitral
valve replacement market such as, Abbott Laboratories, Edward Lifecsiences
3
© Infinium Global Research